Celsion founder steps down and takes away breast cancer treatment business for development
This article was originally published in Clinica
Executive Summary
Celsion's founder and chief scientific officer, Dr Augustine Cheung, is to leave the company and work on further developing the breast cancer treatment he has bought from Celsion in a transaction worth up to $20m.